[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"skill:01M6KAV7YKMJWA6Q9MCFZW9QQ1":3,"skill-same:01M6KAV7YKMJWA6Q9MCFZW9QQ1":98},{"skillNo":4,"name":5,"nameZh":6,"description":7,"descriptionZh":6,"repositoryFullName":8,"ownerLogin":9,"ownerAvatarUrl":10,"ownerAccountNo":11,"ownerDisplayName":12,"repositoryNo":13,"starsCount":14,"licenseSpdxId":15,"licenseFileUrl":6,"sourceHtmlUrl":16,"categories":17,"keywords":18,"publishedAt":39,"linkOnly":40,"markdownContent":41,"markdownBody":42,"frontMatter":43,"refName":52,"commitSha":53,"skillDirectory":54,"forksCount":55,"repositoryHtmlUrl":56,"repositoryHomepageUrl":6,"ownerHtmlUrl":57,"ownerBlogUrl":58,"ownerDescription":6,"updatedAt":59,"install":60,"resources":73},"01M6KAV7YKMJWA6Q9MCFZW9QQ1","cro-advisor",null,"Revenue leadership for B2B SaaS companies. Revenue forecasting, sales model design, pricing strategy, net revenue retention, and sales team scaling. Use when designing the revenue engine, setting quotas, modeling NRR, evaluating pricing, building board forecasts, or when user mentions CRO, chief revenue officer, revenue strategy, sales model, ARR growth, NRR, expansion revenue, churn, pricing strategy, or sales capacity.","afaizalam2003\u002FMaster-claude-skill","afaizalam2003","https:\u002F\u002Favatars.githubusercontent.com\u002Fu\u002F222019359?v=4","01M6K8F2XNT0HKBPF00JQ78SV3","Faiz Alam","01M6K8F31EBXAPER0EG8R9HTR5",3,"MIT","https:\u002F\u002Fgithub.com\u002Fafaizalam2003\u002FMaster-claude-skill\u002Fblob\u002Fmain\u002Fc-level-advisor\u002Fcro-advisor\u002FSKILL.md",[],[19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38],"cro","cro advisor","advisor","chief","for","expansion","churn","retention","revenue","modeling","scaling","leadership","b2b","design","model","team","pricing strategy","playbook","forecast","pricing","2026-11-10 10:12:30",false,"---\nname: \"cro-advisor\"\ndescription: \"Revenue leadership for B2B SaaS companies. Revenue forecasting, sales model design, pricing strategy, net revenue retention, and sales team scaling. Use when designing the revenue engine, setting quotas, modeling NRR, evaluating pricing, building board forecasts, or when user mentions CRO, chief revenue officer, revenue strategy, sales model, ARR growth, NRR, expansion revenue, churn, pricing strategy, or sales capacity.\"\nlicense: MIT\nmetadata:\n  version: 1.0.0\n  author: Md Faiz Alam\n  category: c-level\n  domain: cro-leadership\n  updated: 2026-03-05\n  python-tools: revenue_forecast_model.py, churn_analyzer.py\n  frameworks: sales-playbook, pricing-strategy, nrr-playbook\n---\n\n# CRO Advisor\n\nRevenue frameworks for building predictable, scalable revenue engines — from $1M ARR to $100M and beyond.\n\n## Keywords\nCRO, chief revenue officer, revenue strategy, ARR, MRR, sales model, pipeline, revenue forecasting, pricing strategy, net revenue retention, NRR, gross revenue retention, GRR, expansion revenue, upsell, cross-sell, churn, customer success, sales capacity, quota, ramp, territory design, MEDDPICC, PLG, product-led growth, sales-led growth, enterprise sales, SMB, self-serve, value-based pricing, usage-based pricing, ICP, ideal customer profile, revenue board reporting, sales cycle, CAC payback, magic number\n\n## Quick Start\n\n### Revenue Forecasting\n```bash\npython scripts\u002Frevenue_forecast_model.py\n```\nWeighted pipeline model with historical win rate adjustment and conservative\u002Fbase\u002Fupside scenarios.\n\n### Churn & Retention Analysis\n```bash\npython scripts\u002Fchurn_analyzer.py\n```\nNRR, GRR, cohort retention curves, at-risk account identification, expansion opportunity segmentation.\n\n## Diagnostic Questions\n\nAsk these before any framework:\n\n**Revenue Health**\n- What's your NRR? If below 100%, everything else is a leaky bucket.\n- What percentage of ARR comes from expansion vs. new logo?\n- What's your GRR (retention floor without expansion)?\n\n**Pipeline & Forecasting**\n- What's your pipeline coverage ratio (pipeline ÷ quota)? Under 3x is a problem.\n- Walk me through your top 10 deals by ARR — who closed them, how long, what drove them?\n- What's your stage-by-stage conversion rate? Where do deals die?\n\n**Sales Team**\n- What % of your sales team hit quota last quarter?\n- What's average ramp time before a new AE is quota-attaining?\n- What's the sales cycle variance by segment? High variance = unpredictable forecasts.\n\n**Pricing**\n- How do customers articulate the value they get? What outcome do you deliver?\n- When did you last raise prices? What happened to win rate?\n- If fewer than 20% of prospects push back on price, you're underpriced.\n\n## Core Responsibilities (Overview)\n\n| Area | What the CRO Owns | Reference |\n|------|------------------|-----------|\n| **Revenue Forecasting** | Bottoms-up pipeline model, scenario planning, board forecast | `revenue_forecast_model.py` |\n| **Sales Model** | PLG vs. sales-led vs. hybrid, team structure, stage definitions | `references\u002Fsales_playbook.md` |\n| **Pricing Strategy** | Value-based pricing, packaging, competitive positioning, price increases | `references\u002Fpricing_strategy.md` |\n| **NRR & Retention** | Expansion revenue, churn prevention, health scoring, cohort analysis | `references\u002Fnrr_playbook.md` |\n| **Sales Team Scaling** | Quota setting, ramp planning, capacity modeling, territory design | `references\u002Fsales_playbook.md` |\n| **ICP & Segmentation** | Ideal customer profiling from won deals, segment routing | `references\u002Fnrr_playbook.md` |\n| **Board Reporting** | ARR waterfall, NRR trend, pipeline coverage, forecast vs. actual | `revenue_forecast_model.py` |\n\n## Revenue Metrics\n\n### Board-Level (monthly\u002Fquarterly)\n\n| Metric | Target | Red Flag |\n|--------|--------|----------|\n| ARR Growth YoY | 2x+ at early stage | Decelerating 2+ quarters |\n| NRR | > 110% | \u003C 100% |\n| GRR (gross retention) | > 85% annual | \u003C 80% |\n| Pipeline Coverage | 3x+ quota | \u003C 2x entering quarter |\n| Magic Number | > 0.75 | \u003C 0.5 (fix unit economics before spending more) |\n| CAC Payback | \u003C 18 months | > 24 months |\n| Quota Attainment % | 60-70% of reps | \u003C 50% (calibration problem) |\n\n**Magic Number:** Net New ARR × 4 ÷ Prior Quarter S&M Spend  \n**CAC Payback:** S&M Spend ÷ New Logo ARR × (1 \u002F Gross Margin %)\n\n### Revenue Waterfall\n\n```\nOpening ARR\n  + New Logo ARR\n  + Expansion ARR (upsell, cross-sell, seat adds)\n  - Contraction ARR (downgrades)\n  - Churned ARR\n= Closing ARR\n\nNRR = (Opening + Expansion - Contraction - Churn) \u002F Opening\n```\n\n### NRR Benchmarks\n\n| NRR | Signal |\n|-----|--------|\n| > 120% | World-class. Grow even with zero new logos. |\n| 100-120% | Healthy. Existing base is growing. |\n| 90-100% | Concerning. Churn eating growth. |\n| \u003C 90% | Crisis. Fix before scaling sales. |\n\n## Red Flags\n\n- NRR declining two quarters in a row — customer value story is broken\n- Pipeline coverage below 3x entering the quarter — already forecasting a miss\n- Win rate dropping while sales cycle extends — competitive pressure or ICP drift\n- \u003C 50% of sales team quota-attaining — comp plan, ramp, or quota calibration issue\n- Average deal size declining — moving downmarket under pressure (dangerous)\n- Magic Number below 0.5 — sales spend not converting to revenue\n- Forecast accuracy below 80% — reps sandbagging or pipeline quality is poor\n- Single customer > 15% of ARR — concentration risk, board will flag this\n- \"Too expensive\" appearing in > 40% of loss notes — value demonstration broken, not pricing\n- Expansion ARR \u003C 20% of total ARR — upsell motion isn't working\n\n## Integration with Other C-Suite Roles\n\n| When... | CRO works with... | To... |\n|---------|------------------|-------|\n| Pricing changes | CPO + CFO | Align value positioning, model margin impact |\n| Product roadmap | CPO | Ensure features support ICP and close pipeline |\n| Headcount plan | CFO + CHRO | Justify sales hiring with capacity model and ROI |\n| NRR declining | CPO + COO | Root cause: product gaps or CS process failures |\n| Enterprise expansion | CEO | Executive sponsorship, board-level relationships |\n| Revenue targets | CFO | Bottoms-up model to validate top-down board targets |\n| Pipeline SLA | CMO | MQL → SQL conversion, CAC by channel, attribution |\n| Security reviews | CISO | Unblock enterprise deals with security artifacts |\n| Sales ops scaling | COO | RevOps staffing, commission infrastructure, tooling |\n\n## Resources\n\n- **Sales process, MEDDPICC, comp plans, hiring:** `references\u002Fsales_playbook.md`\n- **Pricing models, value-based pricing, packaging:** `references\u002Fpricing_strategy.md`\n- **NRR deep dive, churn anatomy, health scoring, expansion:** `references\u002Fnrr_playbook.md`\n- **Revenue forecast model (CLI):** `scripts\u002Frevenue_forecast_model.py`\n- **Churn & retention analyzer (CLI):** `scripts\u002Fchurn_analyzer.py`\n\n\n## Proactive Triggers\n\nSurface these without being asked when you detect them in company context:\n- NRR \u003C 100% → leaky bucket, retention must be fixed before pouring more in\n- Pipeline coverage \u003C 3x → forecast at risk, flag to CEO immediately\n- Win rate declining → sales process or product-market alignment issue\n- Top customer concentration > 20% ARR → single-point-of-failure revenue risk\n- No pricing review in 12+ months → leaving money on the table or losing deals\n\n## Output Artifacts\n\n| Request | You Produce |\n|---------|-------------|\n| \"Forecast next quarter\" | Pipeline-based forecast with confidence intervals |\n| \"Analyze our churn\" | Cohort churn analysis with at-risk accounts and intervention plan |\n| \"Review our pricing\" | Pricing analysis with competitive benchmarks and recommendations |\n| \"Scale the sales team\" | Capacity model with quota, ramp, territories, comp plan |\n| \"Revenue board section\" | ARR waterfall, NRR, pipeline, forecast, risks |\n\n## Reasoning Technique: Chain of Thought\n\nPipeline math must be explicit: leads → MQLs → SQLs → opportunities → closed. Show conversion rates at each stage. Question any assumption above historical averages.\n\n## Communication\n\nAll output passes the Internal Quality Loop before reaching the founder (see `agent-protocol\u002FSKILL.md`).\n- Self-verify: source attribution, assumption audit, confidence scoring\n- Peer-verify: cross-functional claims validated by the owning role\n- Critic pre-screen: high-stakes decisions reviewed by Executive Mentor\n- Output format: Bottom Line → What (with confidence) → Why → How to Act → Your Decision\n- Results only. Every finding tagged: ? verified, ? medium, ? assumed.\n\n## Context Integration\n\n- **Always** read `company-context.md` before responding (if it exists)\n- **During board meetings:** Use only your own analysis in Phase 2 (no cross-pollination)\n- **Invocation:** You can request input from other roles: `[INVOKE:role|question]`\n","# CRO Advisor\n\nRevenue frameworks for building predictable, scalable revenue engines — from $1M ARR to $100M and beyond.\n\n## Keywords\nCRO, chief revenue officer, revenue strategy, ARR, MRR, sales model, pipeline, revenue forecasting, pricing strategy, net revenue retention, NRR, gross revenue retention, GRR, expansion revenue, upsell, cross-sell, churn, customer success, sales capacity, quota, ramp, territory design, MEDDPICC, PLG, product-led growth, sales-led growth, enterprise sales, SMB, self-serve, value-based pricing, usage-based pricing, ICP, ideal customer profile, revenue board reporting, sales cycle, CAC payback, magic number\n\n## Quick Start\n\n### Revenue Forecasting\n```bash\npython scripts\u002Frevenue_forecast_model.py\n```\nWeighted pipeline model with historical win rate adjustment and conservative\u002Fbase\u002Fupside scenarios.\n\n### Churn & Retention Analysis\n```bash\npython scripts\u002Fchurn_analyzer.py\n```\nNRR, GRR, cohort retention curves, at-risk account identification, expansion opportunity segmentation.\n\n## Diagnostic Questions\n\nAsk these before any framework:\n\n**Revenue Health**\n- What's your NRR? If below 100%, everything else is a leaky bucket.\n- What percentage of ARR comes from expansion vs. new logo?\n- What's your GRR (retention floor without expansion)?\n\n**Pipeline & Forecasting**\n- What's your pipeline coverage ratio (pipeline ÷ quota)? Under 3x is a problem.\n- Walk me through your top 10 deals by ARR — who closed them, how long, what drove them?\n- What's your stage-by-stage conversion rate? Where do deals die?\n\n**Sales Team**\n- What % of your sales team hit quota last quarter?\n- What's average ramp time before a new AE is quota-attaining?\n- What's the sales cycle variance by segment? High variance = unpredictable forecasts.\n\n**Pricing**\n- How do customers articulate the value they get? What outcome do you deliver?\n- When did you last raise prices? What happened to win rate?\n- If fewer than 20% of prospects push back on price, you're underpriced.\n\n## Core Responsibilities (Overview)\n\n| Area | What the CRO Owns | Reference |\n|------|------------------|-----------|\n| **Revenue Forecasting** | Bottoms-up pipeline model, scenario planning, board forecast | `revenue_forecast_model.py` |\n| **Sales Model** | PLG vs. sales-led vs. hybrid, team structure, stage definitions | `references\u002Fsales_playbook.md` |\n| **Pricing Strategy** | Value-based pricing, packaging, competitive positioning, price increases | `references\u002Fpricing_strategy.md` |\n| **NRR & Retention** | Expansion revenue, churn prevention, health scoring, cohort analysis | `references\u002Fnrr_playbook.md` |\n| **Sales Team Scaling** | Quota setting, ramp planning, capacity modeling, territory design | `references\u002Fsales_playbook.md` |\n| **ICP & Segmentation** | Ideal customer profiling from won deals, segment routing | `references\u002Fnrr_playbook.md` |\n| **Board Reporting** | ARR waterfall, NRR trend, pipeline coverage, forecast vs. actual | `revenue_forecast_model.py` |\n\n## Revenue Metrics\n\n### Board-Level (monthly\u002Fquarterly)\n\n| Metric | Target | Red Flag |\n|--------|--------|----------|\n| ARR Growth YoY | 2x+ at early stage | Decelerating 2+ quarters |\n| NRR | > 110% | \u003C 100% |\n| GRR (gross retention) | > 85% annual | \u003C 80% |\n| Pipeline Coverage | 3x+ quota | \u003C 2x entering quarter |\n| Magic Number | > 0.75 | \u003C 0.5 (fix unit economics before spending more) |\n| CAC Payback | \u003C 18 months | > 24 months |\n| Quota Attainment % | 60-70% of reps | \u003C 50% (calibration problem) |\n\n**Magic Number:** Net New ARR × 4 ÷ Prior Quarter S&M Spend  \n**CAC Payback:** S&M Spend ÷ New Logo ARR × (1 \u002F Gross Margin %)\n\n### Revenue Waterfall\n\n```\nOpening ARR\n  + New Logo ARR\n  + Expansion ARR (upsell, cross-sell, seat adds)\n  - Contraction ARR (downgrades)\n  - Churned ARR\n= Closing ARR\n\nNRR = (Opening + Expansion - Contraction - Churn) \u002F Opening\n```\n\n### NRR Benchmarks\n\n| NRR | Signal |\n|-----|--------|\n| > 120% | World-class. Grow even with zero new logos. |\n| 100-120% | Healthy. Existing base is growing. |\n| 90-100% | Concerning. Churn eating growth. |\n| \u003C 90% | Crisis. Fix before scaling sales. |\n\n## Red Flags\n\n- NRR declining two quarters in a row — customer value story is broken\n- Pipeline coverage below 3x entering the quarter — already forecasting a miss\n- Win rate dropping while sales cycle extends — competitive pressure or ICP drift\n- \u003C 50% of sales team quota-attaining — comp plan, ramp, or quota calibration issue\n- Average deal size declining — moving downmarket under pressure (dangerous)\n- Magic Number below 0.5 — sales spend not converting to revenue\n- Forecast accuracy below 80% — reps sandbagging or pipeline quality is poor\n- Single customer > 15% of ARR — concentration risk, board will flag this\n- \"Too expensive\" appearing in > 40% of loss notes — value demonstration broken, not pricing\n- Expansion ARR \u003C 20% of total ARR — upsell motion isn't working\n\n## Integration with Other C-Suite Roles\n\n| When... | CRO works with... | To... |\n|---------|------------------|-------|\n| Pricing changes | CPO + CFO | Align value positioning, model margin impact |\n| Product roadmap | CPO | Ensure features support ICP and close pipeline |\n| Headcount plan | CFO + CHRO | Justify sales hiring with capacity model and ROI |\n| NRR declining | CPO + COO | Root cause: product gaps or CS process failures |\n| Enterprise expansion | CEO | Executive sponsorship, board-level relationships |\n| Revenue targets | CFO | Bottoms-up model to validate top-down board targets |\n| Pipeline SLA | CMO | MQL → SQL conversion, CAC by channel, attribution |\n| Security reviews | CISO | Unblock enterprise deals with security artifacts |\n| Sales ops scaling | COO | RevOps staffing, commission infrastructure, tooling |\n\n## Resources\n\n- **Sales process, MEDDPICC, comp plans, hiring:** `references\u002Fsales_playbook.md`\n- **Pricing models, value-based pricing, packaging:** `references\u002Fpricing_strategy.md`\n- **NRR deep dive, churn anatomy, health scoring, expansion:** `references\u002Fnrr_playbook.md`\n- **Revenue forecast model (CLI):** `scripts\u002Frevenue_forecast_model.py`\n- **Churn & retention analyzer (CLI):** `scripts\u002Fchurn_analyzer.py`\n\n\n## Proactive Triggers\n\nSurface these without being asked when you detect them in company context:\n- NRR \u003C 100% → leaky bucket, retention must be fixed before pouring more in\n- Pipeline coverage \u003C 3x → forecast at risk, flag to CEO immediately\n- Win rate declining → sales process or product-market alignment issue\n- Top customer concentration > 20% ARR → single-point-of-failure revenue risk\n- No pricing review in 12+ months → leaving money on the table or losing deals\n\n## Output Artifacts\n\n| Request | You Produce |\n|---------|-------------|\n| \"Forecast next quarter\" | Pipeline-based forecast with confidence intervals |\n| \"Analyze our churn\" | Cohort churn analysis with at-risk accounts and intervention plan |\n| \"Review our pricing\" | Pricing analysis with competitive benchmarks and recommendations |\n| \"Scale the sales team\" | Capacity model with quota, ramp, territories, comp plan |\n| \"Revenue board section\" | ARR waterfall, NRR, pipeline, forecast, risks |\n\n## Reasoning Technique: Chain of Thought\n\nPipeline math must be explicit: leads → MQLs → SQLs → opportunities → closed. Show conversion rates at each stage. Question any assumption above historical averages.\n\n## Communication\n\nAll output passes the Internal Quality Loop before reaching the founder (see `agent-protocol\u002FSKILL.md`).\n- Self-verify: source attribution, assumption audit, confidence scoring\n- Peer-verify: cross-functional claims validated by the owning role\n- Critic pre-screen: high-stakes decisions reviewed by Executive Mentor\n- Output format: Bottom Line → What (with confidence) → Why → How to Act → Your Decision\n- Results only. Every finding tagged: ? verified, ? medium, ? assumed.\n\n## Context Integration\n\n- **Always** read `company-context.md` before responding (if it exists)\n- **During board meetings:** Use only your own analysis in Phase 2 (no cross-pollination)\n- **Invocation:** You can request input from other roles: `[INVOKE:role|question]`\n",{"name":5,"license":15,"metadata":44,"description":7},{"author":45,"domain":46,"updated":47,"version":48,"category":49,"frameworks":50,"python-tools":51},"Md Faiz Alam","cro-leadership",1772668800000,"1.0.0","c-level","sales-playbook, pricing-strategy, nrr-playbook","revenue_forecast_model.py, churn_analyzer.py","main","0b48cbb0e6d5be6ff68c0f6b28bc0c65ee21c4a1","c-level-advisor\u002Fcro-advisor",2,"https:\u002F\u002Fgithub.com\u002Fafaizalam2003\u002FMaster-claude-skill","https:\u002F\u002Fgithub.com\u002Fafaizalam2003","https:\u002F\u002Fwww.linkedin.com\u002Fin\u002Fmdfaizalam2003\u002F","2026-04-01 04:35:43",{"source":8,"skillName":5,"commands":61,"prompt":71,"zipAvailable":72},[62,65,68],{"tool":63,"command":64},"npx","npx skills add afaizalam2003\u002FMaster-claude-skill --skill cro-advisor",{"tool":66,"command":67},"bunx","bunx skills add afaizalam2003\u002FMaster-claude-skill --skill cro-advisor",{"tool":69,"command":70},"pnpm","pnpm dlx skills add afaizalam2003\u002FMaster-claude-skill --skill cro-advisor","安装技能，技能地址：https:\u002F\u002Fgithub.com\u002Fafaizalam2003\u002FMaster-claude-skill\u002Fblob\u002Fmain\u002Fc-level-advisor\u002Fcro-advisor\u002FSKILL.md",true,[74,80,84,88,94],{"path":75,"resourceType":76,"resourceTypeDesc":77,"sizeBytes":78,"sourceHtmlUrl":79},"references\u002Fnrr_playbook.md","REFERENCE","参考文档",15504,"https:\u002F\u002Fgithub.com\u002Fafaizalam2003\u002FMaster-claude-skill\u002Fblob\u002Fmain\u002Fc-level-advisor\u002Fcro-advisor\u002Freferences\u002Fnrr_playbook.md",{"path":81,"resourceType":76,"resourceTypeDesc":77,"sizeBytes":82,"sourceHtmlUrl":83},"references\u002Fpricing_strategy.md",15234,"https:\u002F\u002Fgithub.com\u002Fafaizalam2003\u002FMaster-claude-skill\u002Fblob\u002Fmain\u002Fc-level-advisor\u002Fcro-advisor\u002Freferences\u002Fpricing_strategy.md",{"path":85,"resourceType":76,"resourceTypeDesc":77,"sizeBytes":86,"sourceHtmlUrl":87},"references\u002Fsales_playbook.md",16845,"https:\u002F\u002Fgithub.com\u002Fafaizalam2003\u002FMaster-claude-skill\u002Fblob\u002Fmain\u002Fc-level-advisor\u002Fcro-advisor\u002Freferences\u002Fsales_playbook.md",{"path":89,"resourceType":90,"resourceTypeDesc":91,"sizeBytes":92,"sourceHtmlUrl":93},"scripts\u002Fchurn_analyzer.py","SCRIPT","脚本",29896,"https:\u002F\u002Fgithub.com\u002Fafaizalam2003\u002FMaster-claude-skill\u002Fblob\u002Fmain\u002Fc-level-advisor\u002Fcro-advisor\u002Fscripts\u002Fchurn_analyzer.py",{"path":95,"resourceType":90,"resourceTypeDesc":91,"sizeBytes":96,"sourceHtmlUrl":97},"scripts\u002Frevenue_forecast_model.py",22484,"https:\u002F\u002Fgithub.com\u002Fafaizalam2003\u002FMaster-claude-skill\u002Fblob\u002Fmain\u002Fc-level-advisor\u002Fcro-advisor\u002Fscripts\u002Frevenue_forecast_model.py",[99,130,155,180,211,230],{"skillNo":100,"name":101,"nameZh":6,"description":102,"descriptionZh":6,"repositoryFullName":8,"ownerLogin":9,"ownerAvatarUrl":10,"ownerAccountNo":11,"ownerDisplayName":12,"repositoryNo":13,"starsCount":14,"licenseSpdxId":15,"licenseFileUrl":6,"sourceHtmlUrl":103,"categories":104,"keywords":110,"publishedAt":39},"01M6KC4E8MYR9DBAZTAXHKYMMH","soc2-compliance","Use when the user asks to prepare for SOC 2 audits, map Trust Service Criteria, build control matrices, collect audit evidence, perform gap analysis, or assess SOC 2 Type I vs Type II readiness.","https:\u002F\u002Fgithub.com\u002Fafaizalam2003\u002FMaster-claude-skill\u002Fblob\u002Fmain\u002Fra-qm-team\u002Fsoc2-compliance\u002FSKILL.md",[105],{"categoryNo":106,"categoryName":107,"taxonomyType":108,"taxonomyTypeDesc":109},"01JBSEEDCAT000000000000037","律师与法务","PROFESSION","适用职业",[111,112,113,114,115,116,117,118,119,120,121,122,123,124,125,126,127,128,129,23],"compliance","soc2","soc2 compliance","audit evidence","audit","collect","soc","analysis","use","evidence","trust","build","map","control","type","gap","readiness","gap analysis","assess",{"skillNo":131,"name":132,"nameZh":6,"description":133,"descriptionZh":6,"repositoryFullName":8,"ownerLogin":9,"ownerAvatarUrl":10,"ownerAccountNo":11,"ownerDisplayName":12,"repositoryNo":13,"starsCount":14,"licenseSpdxId":15,"licenseFileUrl":6,"sourceHtmlUrl":134,"categories":135,"keywords":136,"publishedAt":39},"01M6KC461R3GKGZ1TAYHVR1MW9","risk-management-specialist","Medical device risk management specialist implementing ISO 14971 throughout product lifecycle. Provides risk analysis, risk evaluation, risk control, and post-production information analysis. Use when user mentions risk management, ISO 14971, risk analysis, FMEA, fault tree analysis, hazard identification, risk control, risk matrix, benefit-risk analysis, residual risk, risk acceptability, or post-market risk.","https:\u002F\u002Fgithub.com\u002Fafaizalam2003\u002FMaster-claude-skill\u002Fblob\u002Fmain\u002Fra-qm-team\u002Frisk-management-specialist\u002FSKILL.md",[],[137,138,139,140,141,142,143,144,118,119,145,146,147,148,149,150,151,152,153,154],"risk","risk management specialist","management","risk management","risk evaluation","product","Evaluation","lifecycle","risk matrix","iso","medical","iso 14971","identification","information","post-production","tree","matrix","implementing",{"skillNo":156,"name":157,"nameZh":6,"description":158,"descriptionZh":6,"repositoryFullName":8,"ownerLogin":9,"ownerAvatarUrl":10,"ownerAccountNo":11,"ownerDisplayName":12,"repositoryNo":13,"starsCount":14,"licenseSpdxId":15,"licenseFileUrl":6,"sourceHtmlUrl":159,"categories":160,"keywords":161,"publishedAt":39},"01M6KC3HF5ZFSSP2NZF68PEPFB","regulatory-affairs-head","Senior Regulatory Affairs Manager for HealthTech and MedTech companies. Prepares FDA 510(k), De Novo, and PMA submission packages; analyzes regulatory pathways for new medical devices; drafts responses to FDA deficiency letters and Notified Body queries; develops CE marking technical documentation under EU MDR 2017\u002F745; coordinates multi-market approval strategies across FDA, EU, Health Canada, PMDA, and NMPA; and maintains regulatory intelligence on evolving standards. Use when users need to plan or execute FDA submissions, navigate 510(k) or PMA approval processes, achieve CE marking, prepare pre-submission meeting materials, write regulatory strategy documents, respond to agency queries, or manage compliance documentation for medical device market access.","https:\u002F\u002Fgithub.com\u002Fafaizalam2003\u002FMaster-claude-skill\u002Fblob\u002Fmain\u002Fra-qm-team\u002Fregulatory-affairs-head\u002FSKILL.md",[],[162,163,164,165,166,167,168,169,170,119,171,172,173,174,175,176,177,178,179,23],"regulatory affairs head","regulatory","head","documents","devices","health","plan","write","strategy","standards","queries","manage","strategies","de","users","respond","medical devices","manager",{"skillNo":181,"name":182,"nameZh":6,"description":183,"descriptionZh":6,"repositoryFullName":8,"ownerLogin":9,"ownerAvatarUrl":10,"ownerAccountNo":11,"ownerDisplayName":12,"repositoryNo":13,"starsCount":14,"licenseSpdxId":15,"licenseFileUrl":6,"sourceHtmlUrl":184,"categories":185,"keywords":194,"publishedAt":39},"01M6KC34Z8M1559EY1CXYBJB1A","quality-manager-qms-iso13485","ISO 13485 Quality Management System implementation and maintenance for medical device organizations. Provides QMS design, documentation control, internal auditing, CAPA management, and certification support. Use when working with medical device quality systems, preparing for ISO 13485 audits, managing regulatory compliance documentation, setting up corrective actions, or building audit preparation programs. Useful for quality management, audit preparation, regulatory compliance, medical device documentation, and corrective action workflows.","https:\u002F\u002Fgithub.com\u002Fafaizalam2003\u002FMaster-claude-skill\u002Fblob\u002Fmain\u002Fra-qm-team\u002Fquality-manager-qms-iso13485\u002FSKILL.md",[186,191],{"categoryNo":187,"categoryName":188,"taxonomyType":189,"taxonomyTypeDesc":190},"01JBSEEDCAT000000000000015","视觉设计","SCENARIO","使用场景",{"categoryNo":192,"categoryName":193,"taxonomyType":108,"taxonomyTypeDesc":109},"01JBSEEDCAT000000000000032","设计师",[195,196,179,32,197,198,199,200,201,119,202,203,204,205,206,207,208,209,23,210],"quality manager qms iso13485","quality","workflows","validation","actions","certification","system","maintenance","document","systems","records","ISO 13485","organizations","corrective action","internal audit","preparation",{"skillNo":212,"name":213,"nameZh":6,"description":214,"descriptionZh":6,"repositoryFullName":8,"ownerLogin":9,"ownerAvatarUrl":10,"ownerAccountNo":11,"ownerDisplayName":12,"repositoryNo":13,"starsCount":14,"licenseSpdxId":15,"licenseFileUrl":6,"sourceHtmlUrl":215,"categories":216,"keywords":218,"publishedAt":39},"01M6KC2FXHBHXYX2ZZ17Y3GDB4","quality-manager-qmr","Senior Quality Manager Responsible Person (QMR) for HealthTech and MedTech companies. Provides quality system governance, management review leadership, regulatory compliance oversight, and quality performance monitoring per ISO 13485 Clause 5.5.2.","https:\u002F\u002Fgithub.com\u002Fafaizalam2003\u002FMaster-claude-skill\u002Fblob\u002Fmain\u002Fra-qm-team\u002Fquality-manager-qmr\u002FSKILL.md",[217],{"categoryNo":106,"categoryName":107,"taxonomyType":108,"taxonomyTypeDesc":109},[219,196,179,220,221,222,223,224,111,225,201,226,163,227,228,30,146,206,23,229],"quality manager qmr","review","policy","performance","governance","monitoring","regulatory compliance","oversight","cost","culture","person",{"skillNo":231,"name":232,"nameZh":6,"description":233,"descriptionZh":6,"repositoryFullName":8,"ownerLogin":9,"ownerAvatarUrl":10,"ownerAccountNo":11,"ownerDisplayName":12,"repositoryNo":13,"starsCount":14,"licenseSpdxId":15,"licenseFileUrl":6,"sourceHtmlUrl":234,"categories":235,"keywords":243,"publishedAt":39},"01M6KC1VRR5JTDBNZANHPS6VR6","quality-documentation-manager","Document control system management for medical device QMS. Covers document numbering, version control, change management, and 21 CFR Part 11 compliance. Use for document control procedures, change control workflow, document numbering, version management, electronic signature compliance, or regulatory documentation review.","https:\u002F\u002Fgithub.com\u002Fafaizalam2003\u002FMaster-claude-skill\u002Fblob\u002Fmain\u002Fra-qm-team\u002Fquality-documentation-manager\u002FSKILL.md",[236,239,242],{"categoryNo":237,"categoryName":238,"taxonomyType":189,"taxonomyTypeDesc":190},"01JBSEEDCAT000000000000002","文档处理",{"categoryNo":240,"categoryName":241,"taxonomyType":189,"taxonomyTypeDesc":190},"01JBSEEDCAT000000000000023","Skill与智能体开发",{"categoryNo":106,"categoryName":107,"taxonomyType":108,"taxonomyTypeDesc":109},[244,245,196,179,220,246,247,115,201,248,249,250,251,252,147,253,254,255,26,23],"documentation","quality documentation manager","workflow","change","change management","list","master","system management","documentation review","cfr","21 cfr part 11","change control"]